Literature DB >> 10082534

Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factors.

C Rusterholz1, P C Henrioud, M Nabholz.   

Abstract

Interleukin-2 (IL-2) responsiveness of T lymphocytes is controlled through transcription of the IL-2 receptor (IL-2R) alpha subunit by antigen and by IL-2 itself. IL-2 induces IL-2Ralpha transcription via an IL-2-responsive enhancer (IL-2rE), whose activity depends on the cooperative binding of IL-2-induced STAT5 to two sites and of constitutively active Elf-1 to a third one. Here we describe the changes in IL-2rE chromatin that occur in normal T lymphocytes upon activation of IL-2Ralpha expression. In cells induced to transiently express IL-2Ralpha with concanavalin A (which mimics antigen), none of the IL-2rE sites is occupied despite the presence of Elf-1 and STAT1, which bind to the IL-2rE in vitro. The two STAT binding sites are occupied rapidly upon IL-2 stimulation, concomitantly with STAT5 activation. Occupation of the Elf-1 binding site is delayed, although Elf-1 concentration and binding activity are not modified by IL-2. Digestion of T-cell chromatin with DNase I and micrococcal nuclease shows that IL-2 induces the appearance of nuclease-hypersensitive sites flanking the IL-2rE. Thus IL-2, in addition to activating STAT5, appears to regulate IL-2Ralpha transcription by making IL-2Ralpha chromatin accessible to transcription factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082534      PMCID: PMC84061          DOI: 10.1128/MCB.19.4.2681

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Antigenic stimulation regulates the expression of IL 2 receptors in a cytolytic T lymphocyte clone.

Authors:  J W Lowenthal; C Tougne; H R MacDonald; K A Smith; M Nabholz
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

2.  Activation of T lymphocytes by lectins and carbohydrate-oxidizing reagents viewed as an immunological recognition of cell-surface modifications seen in the context of "self" major histocompatibility complex antigens.

Authors:  A Kimura; B Ersson
Journal:  Eur J Immunol       Date:  1981-06       Impact factor: 5.532

3.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  The interleukin-2 T-cell system: a new cell growth model.

Authors:  D A Cantrell; K A Smith
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

5.  Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene.

Authors:  J M Depper; W J Leonard; C Drogula; M Krönke; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter.

Authors:  X Y Fu; J J Zhang
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

7.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.

Authors:  F Erard; P Corthesy; K A Smith; W Fiers; A Conzelmann; M Nabholz
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

8.  Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.

Authors:  S L Cross; N F Halden; M J Lenardo; W J Leonard
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

9.  Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression.

Authors:  X Cao; C A Kozak; Y J Liu; M Noguchi; E O'Connell; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  5 in total

1.  Cerebral malaria in mice: interleukin-2 treatment induces accumulation of gammadelta T cells in the brain and alters resistant mice to susceptible-like phenotype.

Authors:  A Haque; H Echchannaoui; R Seguin; J Schwartzman; L H Kasper; S Haque
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

2.  Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene.

Authors:  R Reeves; W J Leonard; M S Nissen
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  Major differences in the responses of primary human leukocyte subsets to IFN-beta.

Authors:  Anette H H van Boxel-Dezaire; Joana A Zula; Yaomin Xu; Richard M Ransohoff; James W Jacobberger; George R Stark
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

4.  Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.

Authors:  R Reljic; S D Wagner; L J Peakman; D T Fearon
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

5.  Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression.

Authors:  Hyun Seung Yoo; Kyuheon Lee; Kwangmin Na; Yong Xu Zhang; Hyun-Ja Lim; TacGhee Yi; Sun U Song; Myung-Shin Jeon
Journal:  Cell Death Dis       Date:  2017-02-23       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.